The efficacy of low-dose tadalafil in patients undergoing hemodialysis with end-stage renal disease
RENAL FAILURE, cilt.39, sa.1, ss.582-587, 2017 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 39 Sayı: 1
- Basım Tarihi: 2017
- Doi Numarası: 10.1080/0886022x.2017.1349678
- Dergi Adı: RENAL FAILURE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.582-587
- Anahtar Kelimeler: End-stage renal disease, hemodialysis, sexual dysfunction, psychology, QUALITY-OF-LIFE, ERECTILE DYSFUNCTION, TRANSPLANT RECIPIENTS, INTERNATIONAL INDEX, INHIBITOR TADALAFIL, CHRONIC DIALYSIS, MEN, DEPRESSION, MANAGEMENT, HEALTH
- Ondokuz Mayıs Üniversitesi Adresli: Evet
Özet
Background: Erectile dysfunction (ED) is a disorder that is frequently observed in people with chronic kidney disease who undergo hemodialysis (HD). In the context of evidence-based medicine, we aimed to investigate the effect of low-dose tadalafil on sexual function in patients undergoing HD.